Women In Psychedelics Network

The Women in Psychedelic (WIP) Network is a collective of brilliant professionals in
the psychedelic industry promoting inclusion and innovation.

[Women In Psychedelics Network @WomenInPsycWIP]

Rick Doblin, Ph.D., founder of @MAPS dedicated activist + champion of healing, and all-around incredible human being, joins host Kaia Roman for an update on all things MDMA & FDA approval. Check out the full episode now!

https://t.co/wZWVu9QdRP

@RickDoblinPhD @KaiaRomanAuthor

[Women In Psychedelics Network @WomenInPsycWIP]

Last week, we received monumental psychedelic news out of Australia. There, regulators decided to allow psilocybin-assisted therapy to treat depression, and MDMA-assisted therapy to treat PTSD (with proper diagnosis and a prescription). Are the US and Canada next?

[Women In Psychedelics Network @WomenInPsycWIP]

Will Massachusetts decriminalize the possession of psychedelic drugs? Two state legislators recently filed a bill aimed at decriminalizing certain psychedelic substances in the state.
https://t.co/GOQx6a7u79

[Women In Psychedelics Network @WomenInPsycWIP]

It came as a surprise to many when Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat PTSD and treatment-resistant depression, respectively.
https://t.co/d9JryECeQ4

[Women In Psychedelics Network @WomenInPsycWIP]

Is this really about the depth and variety of clinical studies going after different health conditions, or is this just hype to accelerate the development of the psychedelic industry as a never-ending cure-all discovery? What are your thoughts?

https://t.co/qHTDnvhQ14

[Women In Psychedelics Network @WomenInPsycWIP]

Apex Labs Ltd., an Iter Investment’s portfolio biopharma company developing psilocybin therapeutics, has been granted approval by Health Canada to begin its large take-home psilocybin clinical trial. 
https://t.co/CoE7DlxUFB

[Women In Psychedelics Network @WomenInPsycWIP]

We are delighted to be a media partner for @PsychedelicScience 2023. Register and be a part of the largest psychedelic gathering in history.

Use Women In Psychedelics discount code WPS15 for 15% off your registration.
@MAPSnews https://t.co/L2HU7x7Xbj

[Women In Psychedelics Network @WomenInPsycWIP]

@Natalie_Lyla @MAPS Joined MAPS in 2014, where she co-developed their Health Equity program. Hear her predictions for how psychedelic legalization will roll out in the coming years and how psychedelic supporters can avoid the mistakes made with medical cannabis. 
Check out the full episode!

[Women In Psychedelics Network @WomenInPsycWIP]

@Natalie_Lyla , Global Impact Officer @Maps, is a woman on a mission! Driven from a young age to fight inequity toward marginalized communities, she helped legalize medical cannabis in New York through her work with the Drug Policy Alliance.

https://t.co/fY8rdu43Wh

[PSYCSpotlight @PSYC_Spot]

Postpartum Depression #Psychedelic Treatment Studied In Reunion's Phase 1 Trial

Reunion Neuroscience has completed the data analysis for its Phase 1 clinical trial with its lead asset RE104, a 4-HO-DiPT prodrug treating #postpartum #depression.

https://t.co/dKsx2L83EK
$REUN

[PSYCSpotlight @PSYC_Spot]

Congress Hops on #Psychedelics Juggernaut with a New Caucus

Two #Congressmen – Lou Correa (D-CA) and Jack Bergman (R-MI) – announced they formed The Psychedelics Advancing Clinical Treatments (PACT) #caucus focused on psychedelics research & therapies.

https://t.co/ylwmlHqUrV

[PSYCSpotlight @PSYC_Spot]

Prince Harry Reveals He Used Psychedelics to Cope with #Grief

The Duke of Sussex' choice of phrase "clear the windshield" is symbolic of his journey with #psychedelics which allowed him to metaphorically clear away all sense of loss he was experiencing.

https://t.co/ckFRU2NVnP

[Women In Psychedelics Network @WomenInPsycWIP]

https://t.co/CcCjFHKeEF

[Women In Psychedelics Network @WomenInPsycWIP]

Little is known about interest among women who experience elevated risk of mental health and substance use disorders. New study examined interest in receiving psychedelic-assisted therapy and socio-structural factors associated with interest among marginalized women.

[Women In Psychedelics Network @WomenInPsycWIP]

Tune in for the who, what, when, where, why, how, and how often, as Victoria and Rome share their wisdom on microdosing + therapeutic support and resources. With so much interest in microdosing these days, this episode is a goldmine of information!

[Women In Psychedelics Network @WomenInPsycWIP]

Meet Victoria Sterkin and Rome Shadanloo, the powerhouse founders of Mycology Psychology. If you want to know all about microdosing psilocybin to create lasting change, these ladies are the ones to listen to.

Check out the latest Psyched episode!
https://t.co/XbICbgoao1

[Women In Psychedelics Network @WomenInPsycWIP]

According to the findings, women used MDMA more than men — about 35 percent of women preferred MDMA, followed by LSD, at more than 25 percent. Nearly 39 percent of men preferred LSD; 22 percent preferred psilocybin mushrooms.

[Women In Psychedelics Network @WomenInPsycWIP]

When it comes to exploring the depths of the subconscious, women are more likely to take the plunge than men, says a 2020 Global Drug Survey.

https://t.co/dJz73O7YAz

[Women In Psychedelics Network @WomenInPsycWIP]

Let’s do a quick tour of some of the latest announcements made by psychedelics companies over the past week. We promise you’ll be informed in less time than it takes to brew your coffee.
https://t.co/8YFlCsMIFn

[Women In Psychedelics Network @WomenInPsycWIP]

Arizona would spend $30 million researching psychedelic mushrooms as a treatment for numerous medical conditions under a bipartisan proposal in the state capitol.

https://t.co/XakBaT0tsr

[Women In Psychedelics Network @WomenInPsycWIP]

A U.S. Department of Veterans Affairs official says the agency is keeping a “very close eye” on psychedelics research and policy amid the growing reform movement.

https://t.co/h91yjsGgxy